Skip to content

Evidence-Based Tobacco Cessation Strategies in Patients With Cancer

Implementing Evidence-Based Tobacco Cessation Strategies in Oncology Clinics

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02211196
Enrollment
377
Registered
2014-08-07
Start date
2013-02-28
Completion date
2014-11-30
Last updated
2018-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant Neoplasm

Brief summary

This pilot clinical trial studies evidence-based tobacco cessation strategies in patients with cancer. Stop-smoking plans suggested by doctors may help patients with cancer quit smoking.

Detailed description

PRIMARY OBJECTIVES: I. To assess oncology providers' self-reported need for training on evidence-based tobacco cessation strategies and assess their level of interest in future training on evidence-based tobacco cessation strategies. II. To test the feasibility of the implementation of evidence-based tobacco cessation strategies in community oncology clinics. III. To test the feasibility of surveying community oncology patients after a clinic visit to assess provider behavior regarding screening and brief intervention for tobacco use. OUTLINE: Patients complete a survey over approximately 10-15 minutes related to their provider's cessation advice and assistance with quitting. After completion of study, patients are followed up at 1 month.

Interventions

BEHAVIORALsmoking cessation intervention

Receive evidence-based tobacco cessation strategies

OTHERsurvey administration

Ancillary studies

OTHERquestionnaire administration

Ancillary studies

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
Wake Forest University Health Sciences
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* All patients with cancer who saw a provider will be eligible

Exclusion criteria

* Having a nurse or lab visit only

Design outcomes

Primary

MeasureTime frameDescription
Percentage of providers from the Piedmont Oncology Association (POA) reporting a need for training on evidence-based tobacco cessation strategiesUp to 1 monthWill be estimated and 95% confidence intervals (CI) constructed.
Percentage reporting feeling very confident in their ability to counsel smokersUp to 1 monthWill be estimated and 95% CI constructed.
Percentage reporting they would be willing to participate in training on evidence-based tobacco cessation strategiesUp to 1 monthWill be estimated and 95% CI constructed.
Proportion of oncology patients willing to complete a survey in an oncology clinicUp to 1 monthWill be estimated and 95% CI constructed.
Proportion of patients who report that their provider asked about tobacco use during their visitUp to 1 monthThese prevalences will be estimated at pre- and post-intervention, and 95% CIs calculated adjusting for the expected within-clinic correlation of patient outcomes. These outcomes will be analyzed further using a subject-specific modeling approach to account for the correlation that occurs due to patients being clustered within clinics.
Proportion of current smokers who report that their provider advised them to quit during their visit and provided tobacco-cessation strategiesUp to 1 monthThese prevalences will be estimated at pre- and post-intervention, and 95% CIs calculated adjusting for the expected within-clinic correlation of patient outcomes. These outcomes will be analyzed further using a subject-specific modeling approach to account for the correlation that occurs due to patients being clustered within clinics.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026